PMA device
Spiration® Valve System
Gyrus Acmi, Inc. · Valve, Pulmonary (NJK, Class III) · First FDA decision Dec 3, 2018, newest Aug 20, 2026COPD and emphysema
Last checked: Nov 20, 2026Source: FDA, CMS, ClinicalTrials.gov, PubMed
FDA decisions
8
PMA pathway
Device trials
16
Naming "Spiration"
MAUDE reports
13
Brand "Spiration", since 2015
PubMed studies
49
Mentioning "Spiration"
AI summary across all sources
Written by AI from the FDA, CMS, ClinicalTrials.gov, MAUDE and PubMed data on this page, plus web searches for payment facts.
Product review deck
A slide deck reviewing Spiration® Valve System
About ten slides on the technology, clinical evidence, regulatory history and commercialization, built with AI from the data on this page and web research, with sources. Download it as PowerPoint to edit or as PDF to share.
- Executive summary and key facts
- Technology
- Clinical evidence and trials
- Regulatory history and safety
- Reimbursement, market and competition
- Risks, outlook and sources
AI-written from public data and may contain mistakes. Check each fact against its source before relying on it. Not investment, legal, reimbursement or medical advice.
FDA decisions
The newest 6 of 8 decisions filed under this name.
- Spiration® Valve SystemPMA supplement
P180007-S016 · Decided Aug 20, 2026 · 16 days after receipt · Normal 180 Day Track No User Fee
Device type: Valve, pulmonary (NJK) · Anesthesiology & Respiratory
- Spiration Valve SystemPMA supplement
P180007-S011 · Decided Sep 22, 2023 · 29 days after receipt · Normal 180 Day Track No User Fee
Device type: Valve, pulmonary (NJK) · Anesthesiology & Respiratory
- Spiration Valve SystemPMA supplement
P180007-S008 · Decided Sep 1, 2021 · 124 days after receipt · Normal 180 Day Track No User Fee
Device type: Valve, pulmonary (NJK) · Anesthesiology & Respiratory
3 more FDA decisions with a free account
Older decisions: P180007-S002, P180007
Medicare coverage
National and local coverage documents whose titles match this device or its device type. Payment add-ons (NTAP, pass-through, TCET) and likely codes are covered in the summary above.
No Medicare coverage document has a title matching this device or device type. Many devices are paid under existing codes without one.
Clinical trials
Device studies on ClinicalTrials.gov that name "Spiration", any status and sponsor, newest update first.
- STRIVE Post-Market Registry StudyRecruiting
Olympus Corporation of the AmericasPublic (7733.T)
NCT04302272 · 150 participants (planned) · Start Oct 9, 2021 · Primary completion Dec 2026
Device: Spiration Valve System (SVS) · For: Emphysema
Sites: Phoenix, Arizona; Mountain View, California; Coral Gables, Florida · 16 sites in all
Beth Israel Deaconess Medical CenterAcademic, hospital or other
NCT07184528 · 20 participants (planned) · Start Jul 1, 2025 · Primary completion Jul 1, 2026
Device: Endobronchial Blood Patch; Spiration Valve System (SVS) Placement · For: Persistent Air Leaks
Sites: Boston, Massachusetts
- Evaluation of the Spiration® Valve System for Emphysema to Improve Lung FunctionPivotal-lookingCompleted
Olympus Corporation of the AmericasPublic (7733.T)
NCT01812447 · 172 participants · Start Jun 2013 · Primary completion Nov 2017
Device: Spiration Valve System · For: Emphysema
Sites: Fort Smith, Arkansas; Riverside, California; San Diego, California · 34 sites in all
13 more trials with a free account
Adverse event reports (MAUDE)
Reports received since 2015 naming the brand "Spiration", and for the whole product code for context.
This brand
13 reports: 4 malfunction, 5 injury, 4 death
Whole product code NJK
2,041 reports: 124 malfunction, 1,732 injury, 185 death
Newest reports for this brand
- SPIRATION VALVE SYSTEMMalfunction
20609169 · Received Nov 5, 2024 · Event dated Jul 31, 2024
Device type: Valve, Pulmonary (NJK)
Patient problem as coded: No Clinical Signs, Symptoms or Conditions
3004450998-2024-00045 · Received Oct 22, 2024
Device type: Valve, Pulmonary (NJK)
Device problem as coded: Adverse Event Without Identified Device or Use Problem
Patient problem as coded: Insufficient Information
- SPIRATION VALVEInjury
3004450998-2023-00044 · Received Jul 12, 2023 · Event dated Jun 13, 2023
Device type: One-Way Air-Leak Valve (OAZ)
Device problem as coded: Off-Label Use
Patient problem as coded: Hypoxia; Ventilator Dependent
2 more reports with a free account
Recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
Olympus Corporation of the Americas
Z-0551-2022 · Started Dec 23, 2021
Reason given: Mislabeled Patient Charge Label indicating model number SVS-V7-00 (7mm) instead of SVS-V9-00 (9mm)
Cause as FDA categorized it: Labeling Change Control · Device type: Valve, Pulmonary (NJK)
Published research
The most relevant PubMed records for "Spiration"[tiab]. The summary above synthesizes these.
- Bronchoscopic endobronchial valves.
Cosgun T, Yardimci H, Tezel Ç · Breathe (Sheff) · 2026Review
- Bronchoscopic Treatment of Emphysema.
Irandost M, Frye LK · Clin Chest Med · 2025Review
- Hypoxemia After Endobronchial Valve Deployment for Persistent Air Leak.
Boulos R, Anam K, Bhandary S, et al. · J Cardiothorac Vasc Anesth · 2023
- Indenyl-thiazole and indenyl-formazan derivatives: Synthesis, anticancer screening studies, molecular-docking, and pharmacokinetic/ molin-spiration properties.
Alfaifi GH, Farghaly TA, Magda H Abdellattif · PLoS One · 2023Research Support, Non-U.S. Gov't
- Efficacy and safety of simultaneous combined Zephyr and Spiration valve therapy in patients with advanced pulmonary emphysema.
Dittrich AS, Kontogianni K, Unterschemmann AS, et al. · Respir Med · 2024
- Intrabronchial Valves for Air Leaks After Lobectomy, Segmentectomy, and Lung Volume Reduction Surgery.
Abu-Hijleh M, Styrvoky K, Anand V, et al. · Lung · 2019Multicenter Study, Research Support, Non-U.S. Gov't
- Persistent air leak management in critically ill patients.
Kurman JS · J Thorac Dis · 2021Review
- Bronchoscopic valves for prolonged air leak: current status and technique.
Mahajan AK, Khandhar SJ · J Thorac Dis · 2017Review
- Bronchoscopic Lung Volume Reduction with Valves and Coils. A Network Meta-analysis.
Iftikhar IH, Schimmel M, Sardi A, et al. · Ann Am Thorac Soc · 2020Network Meta-Analysis
- Sustained Clinical Benefits of Spiration Valve System in Patients with Severe Emphysema: 24-Month Follow-Up of EMPROVE.
Criner GJ, Mallea JM, Abu-Hijleh M, et al. · Ann Am Thorac Soc · 2024Randomized Controlled Trial, Multicenter Study
- Efficacy and safety of the Spiration Valve Systemࡊ for the treatment of severe emphysema in patients with Alpha-1 antitrypsin deficiency (EMPROVE).
Hogarth DK, Delage A, Zgoda MA, et al. · Respir Med · 2024Multicenter Study
- Endoscopic Lung Volume Reduction: Review of the EMPROVE and LIBERATE trials.
Nada KM, Nishi S · Mayo Clin Proc Innov Qual Outcomes · 2021Review
Other devices of this type
Also filed under product code NJK.
- Zephyr Endobronchial Valve SystemPulmonx Corporation · PMA 2024
- Zephyr Valve Reigstry (ZEVR)Pulmonx Corporation · PMA 2023
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.